Mascarell L - Search Results

1

New insights into ragweed pollen allergens.

Bordas-Le Floch V, Groeme R, Chabre H, Baron-Bodo V, Nony E, Mascarell L, Moingeon P. Bordas-Le Floch V, et al. Among authors: mascarell l. Curr Allergy Asthma Rep. 2015 Nov;15(11):63. doi: 10.1007/s11882-015-0565-6. Curr Allergy Asthma Rep. 2015. PMID: 26383916 Review.

2

Novel ways for immune intervention in immunotherapy: mucosal allergy vaccines.

Mascarell L, Van Overtvelt L, Moingeon P. Mascarell L, et al. Immunol Allergy Clin North Am. 2006 May;26(2):283-306, vii-viii. doi: 10.1016/j.iac.2006.02.009. Immunol Allergy Clin North Am. 2006. PMID: 16701145 Review.

3

Improvement of sublingual immunotherapy efficacy with a mucoadhesive allergen formulation.

Razafindratsita A, Saint-Lu N, Mascarell L, Berjont N, Bardon T, Betbeder D, Van Overtvelt L, Moingeon P. Razafindratsita A, et al. Among authors: mascarell l. J Allergy Clin Immunol. 2007 Aug;120(2):278-85. doi: 10.1016/j.jaci.2007.04.009. Epub 2007 May 25. J Allergy Clin Immunol. 2007. PMID: 17531296

4

IL-10-inducing adjuvants enhance sublingual immunotherapy efficacy in a murine asthma model.

Van Overtvelt L, Lombardi V, Razafindratsita A, Saint-Lu N, Horiot S, Moussu H, Mascarell L, Moingeon P. Van Overtvelt L, et al. Among authors: mascarell l. Int Arch Allergy Immunol. 2008;145(2):152-62. doi: 10.1159/000108140. Epub 2007 Sep 11. Int Arch Allergy Immunol. 2008. PMID: 17848808

5

A synthetic triacylated pseudo-dipeptide molecule promotes Th1/TReg immune responses and enhances tolerance induction via the sublingual route.

Mascarell L, Van Overtvelt L, Lombardi V, Razafindratsita A, Moussu H, Horiot S, Chabre H, Limal D, Moutel S, Bauer J, Chiavaroli C, Moingeon P. Mascarell L, et al. Vaccine. 2007 Dec 21;26(1):108-18. doi: 10.1016/j.vaccine.2007.10.050. Epub 2007 Nov 9. Vaccine. 2007. PMID: 18063445

6

Toll-like receptor 2 agonist Pam3CSK4 enhances the induction of antigen-specific tolerance via the sublingual route.

Lombardi V, Van Overtvelt L, Horiot S, Moussu H, Chabre H, Louise A, Balazuc AM, Mascarell L, Moingeon P. Lombardi V, et al. Among authors: mascarell l. Clin Exp Allergy. 2008 Nov;38(11):1819-29. doi: 10.1111/j.1365-2222.2008.03056.x. Epub 2008 Jul 17. Clin Exp Allergy. 2008. PMID: 18644025

7

Oral dendritic cells mediate antigen-specific tolerance by stimulating TH1 and regulatory CD4+ T cells.

Mascarell L, Lombardi V, Louise A, Saint-Lu N, Chabre H, Moussu H, Betbeder D, Balazuc AM, Van Overtvelt L, Moingeon P. Mascarell L, et al. J Allergy Clin Immunol. 2008 Sep;122(3):603-9.e5. doi: 10.1016/j.jaci.2008.06.034. J Allergy Clin Immunol. 2008. PMID: 18774396

8

Targeting the allergen to oral dendritic cells with mucoadhesive chitosan particles enhances tolerance induction.

Saint-Lu N, Tourdot S, Razafindratsita A, Mascarell L, Berjont N, Chabre H, Louise A, Van Overtvelt L, Moingeon P. Saint-Lu N, et al. Among authors: mascarell l. Allergy. 2009 Jul;64(7):1003-13. doi: 10.1111/j.1398-9995.2009.01945.x. Epub 2009 Feb 12. Allergy. 2009. PMID: 19220212

9

Mapping of the lingual immune system reveals the presence of both regulatory and effector CD4+ T cells.

Mascarell L, Lombardi V, Zimmer A, Louise A, Tourdot S, Van Overtvelt L, Moingeon P. Mascarell L, et al. Clin Exp Allergy. 2009 Dec;39(12):1910-9. doi: 10.1111/j.1365-2222.2009.03337.x. Epub 2009 Aug 20. Clin Exp Allergy. 2009. PMID: 19694757

10

Lactic acid bacteria as adjuvants for sublingual allergy vaccines.

Van Overtvelt L, Moussu H, Horiot S, Samson S, Lombardi V, Mascarell L, van de Moer A, Bourdet-Sicard R, Moingeon P. Van Overtvelt L, et al. Among authors: mascarell l. Vaccine. 2010 Apr 9;28(17):2986-92. doi: 10.1016/j.vaccine.2010.02.009. Epub 2010 Feb 20. Vaccine. 2010. PMID: 20175969

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

74 results

Search Page